Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma.
Saved in:
| Title: | Continuous R-DA-EDOCH alternated with high-dose Ara-C induces deep remission and overcomes high-risk factors in young patients with newly diagnosed mantle cell lymphoma. |
|---|---|
| Authors: | Yi Wang1,2 zoudehui@ihcams.ac.cn, Yuting Yan1,2, Dandan Shan1,2, Jiawen Chen1,2, Wei Liu1,2, Tingyu Wang1,2, Gang An1,2, Weiwei Sui1,2, Wenyang Huang1,2, Wenjie Xiong1,2, Huimin Liu1,2, Qi Sun1,2, Huijun Wang1,2, Zhijian Xiao1,2, Jianxiang Wang1,2, Lugui Qiu1,2, Dehui Zou1,2 yishuhua@ihcams.ac.cn, Shuhua Yi1,2 |
| Source: | Cancer Biology & Medicine. Feb2025, Vol. 22 Issue 2, p177-189. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 20953941 |
|---|---|
| DOI: | 10.20892/j.issn.2095-3941.2024.0200 |
